PHX.AX ASX
PharmX Technologies Limited
1W: -3.0%
1M: +9.1%
3M: -12.7%
YTD: -28.9%
A$0.10 ($0.07)
+0.00 (+0.00%)
Weekly Expected Move ±8.9%
A$0
A$0
A$0
A$0
A$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$19M
-36.9% ▼
Total Liabilities
$3M
-79.1% ▼
Shareholders Equity
$16M
-0.3% ▼
Cash & Investments
$4M
-68.2% ▼
Total Debt
$894K
+272.5% ▲
Net Debt
-$3M
+74.6% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2024 |
|---|---|
| — Assets — | |
| Cash | $4M |
| Short-Term Investments | $0 |
| Cash & ST Investments | $4M |
| Net Receivables | $1M |
| Inventory | $0 |
| Other Current Assets | $469K |
| Total Current Assets | $6M |
| Property, Plant & Equip. | $806K |
| Goodwill & Intangibles | $12M |
| Long-Term Investments | $0 |
| Other Non-Current Assets | $306K |
| Total Non-Current Assets | $13M |
| Total Assets | $19M |
| — Liabilities — | |
| Accounts Payable | $515K |
| Short-Term Debt | $0 |
| Deferred Revenue | $28K |
| Other Current Liabilities | $137K |
| Total Current Liabilities | $2M |
| Long-Term Debt | $0 |
| Other Non-Current Liab. | $64K |
| Total Non-Current Liabilities | $1M |
| Total Liabilities | $3M |
| — Equity — | |
| Common Stock | $94M |
| Retained Earnings | -$78M |
| Accumulated OCI | $244K |
| Total Stockholders Equity | $16M |
| Total Liabilities & Equity | $19M |
| — Key Metrics — | |
| Total Debt | $894K |
| Net Debt | -$3M |
| Total Investments | $0 |